42.8 F
New York
Wednesday, November 30, 2022



PharmAbbie, Inc. Announces the Launch of a Reg D-506(c) Common Stock Offering

Related Articles

Groton, CT, June 09, 2021 –(PR.com)– PharmAbbie, Inc. is pleased to announce today that it will offer up to 3,191,489 shares of its Class D Common Stock at an offering price of $4.70 per share for an aggregate offering amount of $15,000,000. The shares will be offered to accredited investors only pursuant to Regulation D, Rule 506(c) under the Securities Act of 1933, as amended (the “Security Act”). Purchasers are required to verify their “accredited investor” status.

Incorporated in Delaware and located in Groton, Connecticut, PharmAbbie, Inc. is a late-stage companion animal pharmaceutical development company with six products in various stages of regulatory approval at the United States Food and Drug Administration’s Center for Veterinary Medicine (“FDA-CVM”). PharmAbbie focuses on four therapeutic areas, representing more than half of all veterinary prescriptions: pain and inflammation, anti-infectives,…

Read more…

Popular Articles